HK Stock MarketDetailed Quotes
00460 SIHUAN PHARM
- 0.690
- 0.0000.00%
Market Closed Nov 29 16:08 CST
6.42BMarket Cap-172500P/E (TTM)
0.700High0.680Low8.76MVolume0.690Open0.690Pre Close6.04MTurnover0.09%Turnover RatioLossP/E (Static)9.31BShares1.02052wk High1.33P/B6.42BFloat Cap0.46952wk Low0.02Dividend TTM9.31BShs Float6.005Historical High--Dividend LFY2.90%Amplitude0.301Historical Low0.689Avg Price1000Lot Size3.04%Div YieldTTM--Div Yield LFY
SIHUAN PHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.04%949.7M | -14.70%1.86B | -27.90%1.06B | -28.21%2.18B | -23.23%1.46B | 23.30%3.04B | 80.86%1.91B | -14.39%2.46B | -36.56%1.05B | -1.34%2.88B |
| Operating income | -10.04%949.7M | -14.70%1.86B | -27.90%1.06B | -28.21%2.18B | -23.23%1.46B | 23.30%3.04B | 80.86%1.91B | -14.39%2.46B | -36.56%1.05B | -1.34%2.88B |
| Cost of sales | -10.78%-341.18M | 18.56%-564.9M | 33.12%-307.97M | -14.10%-693.61M | -4.64%-460.51M | -10.57%-607.9M | -63.92%-440.1M | 6.66%-549.78M | 8.76%-268.48M | -9.41%-588.99M |
| Operating expenses | -10.78%-341.18M | 18.56%-564.9M | 33.12%-307.97M | -14.10%-693.61M | -4.64%-460.51M | -10.57%-607.9M | -63.92%-440.1M | 6.66%-549.78M | 8.76%-268.48M | -9.41%-588.99M |
| Gross profit | -18.62%608.52M | -12.90%1.3B | -25.50%747.73M | -38.79%1.49B | -31.59%1B | 26.95%2.43B | 86.64%1.47B | -16.38%1.91B | -42.54%786.06M | -3.77%2.29B |
| Selling expenses | -0.46%-213.47M | 6.13%-442.26M | 7.47%-212.49M | 12.22%-471.14M | 11.99%-229.64M | -45.54%-536.74M | -91.13%-260.92M | -50.29%-368.79M | -13.51%-136.52M | 9.49%-245.38M |
| Administrative expenses | -13.28%-240.34M | 15.07%-468.96M | 33.76%-212.17M | 6.76%-552.19M | -14.95%-320.31M | -20.91%-592.22M | -31.35%-278.66M | -3.86%-489.78M | 6.88%-212.16M | -19.05%-471.57M |
| Research and development expenses | 33.48%-195.59M | 38.32%-577.66M | 35.70%-294.04M | -7.89%-936.58M | -37.08%-457.27M | -19.05%-868.07M | -10.87%-333.57M | -21.74%-729.16M | -20.51%-300.85M | -24.70%-598.95M |
| Impairment and provision | ---- | ---- | ---- | -1,215.43%-1.73B | ---98.1M | ---131.3M | ---- | ---- | ---- | ---3.97B |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---98.1M | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.97B |
| -Other impairment is provision | ---- | ---- | ---- | -1,215.43%-1.73B | ---- | ---131.3M | ---- | ---- | ---- | ---- |
| Special items of operating profit | 28.06%149.98M | -3.74%354.93M | -61.58%117.12M | -21.51%368.73M | 4.39%304.8M | 2.04%469.78M | 63.49%291.99M | -22.21%460.41M | -49.88%178.6M | -25.50%591.85M |
| Operating profit | -25.35%109.1M | 108.83%161.7M | -28.06%146.16M | -337.16%-1.83B | -77.07%203.18M | -1.93%771.95M | 181.14%885.96M | 132.71%787.13M | 118.35%315.14M | -218.77%-2.41B |
| Financing cost | 0.81%-132.46M | -27.54%-269.34M | -34.35%-133.54M | -79.95%-211.18M | -529.99%-99.4M | -1,328.15%-117.35M | -894.83%-15.78M | -74.31%-8.22M | 37.01%-1.59M | 22.21%-4.71M |
| Special items of earning before tax | 109.07%4.14M | 33.70%-53.62M | 4.32%-45.67M | 49.00%-80.88M | 5.85%-47.73M | -1,113.88%-158.58M | -343.60%-50.7M | -8.72%-13.06M | -61.13%-11.43M | -55.69%-12.02M |
| Earning before tax | 41.88%-19.21M | 92.40%-161.26M | -158.98%-33.05M | -527.97%-2.12B | -93.16%56.04M | -35.23%496.01M | 171.24%819.48M | 131.61%765.84M | 117.50%302.12M | -220.42%-2.42B |
| Tax | 43.24%-48.75M | 51.00%-96.43M | 43.47%-85.89M | 22.25%-196.79M | 32.55%-151.94M | -15.56%-253.12M | -68.83%-225.27M | 24.57%-219.04M | 43.75%-133.43M | 12.75%-290.39M |
| After-tax profit from continuing operations | 42.86%-67.96M | 88.89%-257.69M | -24.02%-118.94M | -1,054.97%-2.32B | -116.14%-95.9M | -55.58%242.89M | 252.25%594.22M | 120.15%546.8M | 108.59%168.69M | -261.57%-2.71B |
| After-tax profit from non-continuing business | ---- | ---- | ---- | 458.51%36.3M | ---- | 71.01%-10.12M | ---- | 20.59%-34.92M | ---24.44M | ---43.97M |
| Earning after tax | 42.86%-67.96M | 88.71%-257.69M | -24.02%-118.94M | -1,080.92%-2.28B | -116.14%-95.9M | -54.53%232.77M | 311.92%594.22M | 118.56%511.89M | 107.34%144.26M | -264.19%-2.76B |
| Minority profit | 50.16%-34.53M | 44.71%-203.67M | 49.15%-69.3M | -100.48%-368.36M | -692.03%-136.28M | -577.18%-183.74M | -200.12%-17.21M | 1,067.71%38.51M | -110.26%-5.73M | -106.70%-3.98M |
| Profit attributable to shareholders | 32.67%-33.42M | 97.18%-54.02M | -222.95%-49.64M | -559.75%-1.91B | -93.40%40.38M | -12.01%416.51M | 307.64%611.42M | 117.19%473.38M | 107.43%149.99M | -269.96%-2.75B |
| Basic earnings per share | 32.08%-0.0036 | 97.17%-0.0058 | -223.26%-0.0053 | -564.25%-0.2052 | -93.34%0.0043 | -11.60%0.0442 | 308.86%0.0646 | 117.18%0.05 | 107.41%0.0158 | -270.18%-0.291 |
| Diluted earnings per share | 32.08%-0.0036 | 97.17%-0.0058 | -223.26%-0.0053 | -567.43%-0.2052 | -93.30%0.0043 | -12.20%0.0439 | 306.33%0.0642 | 117.18%0.05 | 107.41%0.0158 | -270.18%-0.291 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data